Showing results (51-60 of 510) with videos related to
Sort By:
Pageof 51
Clinical and Diagnostic Laboratory Immunology|March 7, 2000
Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccinesT Asai, W J Storkus, T L WhitesideCancer|March 1, 1977
Immunologic characterization of chronic lymphocytic leukemia cellsT L Whiteside, A Winkelstein, B S RabinHuman Immunology|June 1, 1990
Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin 2L Vaccarello, Y L Wang, T L WhitesideMolecular and Cellular Biochemistry|August 1, 1997
Ionizing radiation and TNF-alpha stimulate gene expression of a Thr/Tyr-protein phosphatase HVH1 and inhibitory factor IkappaB alpha in human squamous carcinoma cellsU Kasid, F H Wang, T L WhitesideArchives of Otolaryngology--Head & Neck Surgery|November 1, 1993
Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growthW C Lin, S Yasumura, T L WhitesideHNO|March 11, 2005
[Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy]T K Hoffmann, T L Whiteside, H BierCellular Immunology|December 1, 1993
Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cellsH Rabinowich, R B Herberman, T L WhitesideThe American Journal of Pathology|April 1, 1981
Circulating and deposited immune complexes in patients with glomerular disease: immunopathologic correlationsI Stachura, T L Whiteside, R H KellyJournal of Hematotherapy|August 1, 1995
The role of natural killer cells in the treatment of chronic myeloid leukemiaL M Silla, T L Whiteside, E D BallAnticancer Research|July 1, 1996
Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancerT L Whiteside, K Chikamatsu, S Nagashima, et al.Pageof 51